ReviewBiological procedures online2026
Key molecular mechanisms and regulatory networks in colorectal cancer liver metastasis.
Review in Biological procedures online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Colorectal cancer (CRC) continues to show rising incidence and mortality worldwide, with liver metastasis representing the leading cause of death among affected patients. Epidemiological data indicate that approximately 49% of CRC-related deaths are associated with hepatic metastases, and about 25% of patients still develop liver metastasis even after undergoing curative resection. The interplay of various cytokines and immune cells within the tumor microenvironment (TME), along with tumor metabolic reprogramming and gut microbiota, collectively underpins the process of colorectal cancer liver metastasis (CRLM). To date, multiple genes, signaling pathways, and cellular components have been identified as key contributors to the development of CRLM. Although the precise mechanisms driving CRLM remain incompletely understood, emerging evidence suggests that liver metastasis is not restricted to advanced CRC stages and may already be present in a subset of early-stage patients. Based on current evidence, this review proposes that effective anti-metastatic strategies should shift from single-pathway targeting toward integrated interventions that simultaneously regulate the following three dimensions: circulating tumor cells (and their EMT process) as the ‘seeds’, the tumor microenvironment as the ‘soil’, and the gut microbiota and metabolic reprogramming as the ‘environmental modifiers’. This article systematically summarizes the mechanisms and recent advances in the molecular regulatory networks underlying colorectal cancer liver metastasis, with a particular focus on the roles of immune cells and related cytokines in the tumor microenvironment. It aims to provide new insights and potential therapeutic targets for the comprehensive management of this disease and highlights the need to further investigate interactions among these mechanisms, accelerate the development of translational biomarkers, and thereby drive key breakthroughs in the field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.